SYMPHOGEN Trademark

Trademark Overview


On Friday, October 2, 2009, a trademark application was filed for SYMPHOGEN with the United States Patent and Trademark Office. The USPTO has given the SYMPHOGEN trademark a serial number of 79075883. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, March 2, 2021. This trademark is owned by Symphogen AS. The SYMPHOGEN trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cancer, AIDS (Acquired Immune Deficiency Syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases, Idiopathic Thrombocytopenic Purpura (ITP), Hemolytic Disease of Newborns (HDN), smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseases, hematological diseases, and respiratory diseases; veterinary preparations for cancer, AIDS (Acquired Immune Deficiency Syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases, smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseases, and hematological diseases; pharmaceutical preparations based on antibodies, including human, animal, monoclonal and polyclonal antibodies for the treatment of...

Chemicals used in industry, science and photography; biochemicals, namely, human and animal, monoclonal and polyclonal antibodies for in-vivo or in-vitro scientific research and development, including scientific research into diseases, in particular cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases

[ Patent licensing; Patent and industrial property consultation; licensing of industrial property within medical science ]

Research in the field of medical science, including biological research and in particular research into antibodies, including human, animal, monoclonal and polyclonal antibodies and the development of medicines based on antibodies, including human, animal, monoclonal and polyclonal antibodies; chemical analyses; [ computer programming, namely, computer programming for the gathering and processing of medical data in connection with medical science research, development and therapy, including research into, development of, and therapy using antibodies, including human, animal, monoclonal and polyclonal antibodies ]
symphogen

General Information


Serial Number79075883
Word MarkSYMPHOGEN
Filing DateFriday, October 2, 2009
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, March 2, 2021
Registration Number3882672
Registration DateTuesday, November 30, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2010

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cancer, AIDS (Acquired Immune Deficiency Syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases, Idiopathic Thrombocytopenic Purpura (ITP), Hemolytic Disease of Newborns (HDN), smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseases, hematological diseases, and respiratory diseases; veterinary preparations for cancer, AIDS (Acquired Immune Deficiency Syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases, smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseases, and hematological diseases; pharmaceutical preparations based on antibodies, including human, animal, monoclonal and polyclonal antibodies for the treatment of cancer, AIDS (Acquired Immune Deficiency Syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases, Indiopathic Thrombocytopenic Purpura (ITP), Hemolytic Disease of Newborns (HDN) smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseases, Hematological diseases and respiratory diseases; dietetic foods adapted for medical use
Goods and ServicesChemicals used in industry, science and photography; biochemicals, namely, human and animal, monoclonal and polyclonal antibodies for in-vivo or in-vitro scientific research and development, including scientific research into diseases, in particular cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases
Goods and Services[ Patent licensing; Patent and industrial property consultation; licensing of industrial property within medical science ]
Goods and ServicesResearch in the field of medical science, including biological research and in particular research into antibodies, including human, animal, monoclonal and polyclonal antibodies and the development of medicines based on antibodies, including human, animal, monoclonal and polyclonal antibodies; chemical analyses; [ computer programming, namely, computer programming for the gathering and processing of medical data in connection with medical science research, development and therapy, including research into, development of, and therapy using antibodies, including human, animal, monoclonal and polyclonal antibodies ]

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2009
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2009
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateWednesday, March 15, 2017
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSymphogen A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDK

Party NameSymphogen AS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDK

Party NameSymphogen AS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Monday, June 20, 2022NEW REPRESENTATIVE AT IB RECEIVED
Saturday, June 11, 2022NEW REPRESENTATIVE AT IB RECEIVED
Saturday, April 23, 2022PARTIAL INVALIDATION PROCESSED BY THE IB
Saturday, March 12, 2022PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, March 12, 2022INVALIDATION PROCESSED
Tuesday, November 2, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, March 2, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, March 2, 2021REGISTERED-SEC.71 ACCEPTED
Tuesday, March 2, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 16, 2020TEAS SECTION 71 RECEIVED
Friday, October 30, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 30, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 30, 2020TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, October 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 30, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 23, 2020NEW REPRESENTATIVE AT IB RECEIVED
Saturday, November 30, 2019COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, October 17, 2019INTERNATIONAL REGISTRATION RENEWED
Thursday, August 8, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, January 11, 2018PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, December 1, 2017PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, December 1, 2017INVALIDATION PROCESSED
Wednesday, November 15, 2017PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, March 15, 2017NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Wednesday, March 15, 2017REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Wednesday, March 15, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 9, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, March 2, 2017NEW REPRESENTATIVE AT IB RECEIVED
Monday, October 3, 2016TEAS SECTION 71 & 15 RECEIVED
Monday, February 18, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, March 31, 2011FINAL DISPOSITION NOTICE SENT TO IB
Thursday, March 31, 2011FINAL DISPOSITION PROCESSED
Monday, February 28, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 30, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, September 14, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2010PUBLISHED FOR OPPOSITION
Thursday, August 12, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 12, 2010ASSIGNED TO LIE
Tuesday, July 27, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 27, 2010EXAMINER'S AMENDMENT ENTERED
Tuesday, July 27, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 27, 2010EXAMINERS AMENDMENT E-MAILED
Tuesday, July 27, 2010EXAMINERS AMENDMENT -WRITTEN
Thursday, July 1, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 1, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 1, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 30, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 30, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 29, 2010REFUSAL PROCESSED BY IB
Tuesday, January 5, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 5, 2010REFUSAL PROCESSED BY MPU
Saturday, January 2, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 1, 2010NON-FINAL ACTION WRITTEN
Wednesday, December 30, 2009ASSIGNED TO EXAMINER
Saturday, December 26, 2009APPLICATION FILING RECEIPT MAILED
Tuesday, December 22, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 17, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB